Mitochondrial membrane permeabilization upon interaction with lysozyme fibrillation products: Role of mitochondrial heterogeneity  by Meratan, Ali Akbar & Nemat-Gorgani, Mohsen
Biochimica et Biophysica Acta 1818 (2012) 2149–2157
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemMitochondrial membrane permeabilization upon interaction with lysozyme
ﬁbrillation products: Role of mitochondrial heterogeneity
Ali Akbar Meratan a, Mohsen Nemat-Gorgani a,b,⁎
a Institute of Biochemistry and Biophysics, University of Tehran, P.O. Box 13145-1384, Tehran, Iran
b Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USAAbbreviations: HEWL, hen egg white lysozyme; OS,
oxygen species; DLS, dynamic light scattering;MDH,malate
dehydrogenase; CS, citrate synthase; AK, adenylate kinase; E
acid
⁎ Corresponding author at: Institute of Biochemistry
Tehran, P.O. Box 13145-1384, Tehran, Iran. Tel.: +1 650 8
E-mail addresses: gorganim@ibb.ut.ac.ir, mohsenn@
(M. Nemat-Gorgani).
0005-2736/$ – see front matter © 2012 Elsevier B.V. All
doi:10.1016/j.bbamem.2012.04.020a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 October 2011
Received in revised form 18 April 2012
Accepted 26 April 2012






Neurodegenerative disorderMitochondrial dysfunction is a common feature of many neurodegenerative disorders, although the relative
degree of this functional impairment and the mechanism of selective vulnerability in different regions of the
brain related to various neurological diseases are not completely understood. In a recent study, we reported
on brain mitochondrial membrane permeabilization upon interaction with hen egg white lysozyme (HEWL)
protoﬁbrils, and came to the conclusion that mitochondrial heterogeneity could offer an explanation for some
of our observations. Accordingly, the ﬁrst part of the present investigation was devoted on studies involving
interaction of HEWL ﬁbrillation products with mitochondria isolated from various areas of the brain, known
to be affected in a number of well-characterized neurodegenerative conditions. This was followed by looking
at heart and liver mitochondria. Membrane permeabilization was investigated by monitoring release of
mitochondrial enzymes. Mitochondria isolated from cortex and hippocampus showed greater sensitivities
than those prepared from substantia nigra. Results clearly demonstrate heterogeneity in brain mitochondria
together with a higher resistance to permeabilization in these organelles in comparison with those isolated
from liver and heart. Calcium and spermine were found to be more effective in preventing permeabilization
in brain mitochondria, as compared to liver and heart. The structure–function aspects and physiological
signiﬁcance of the observations in relation to differences in composition, biophysical nature and
morphological properties of mitochondria are discussed. It is argued that studies on heterogeneity in cellular
membranes, the primary targets of toxic protoﬁbrils, may provide important insights into mechanism of
toxicity, with clinical and pathological manifestations.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Amyloidoses constitute a large group of disorders deﬁned by the
presence of insoluble protein deposits in different tissues [1,2].
Although, most forms of amyloidoses are neurodegenerative
disorders, these abnormal conditions may be divided into three classes:
(i) neurodegenerative conditions, where protein aggregates appear in
the central or peripheral nervous system; (ii) non-neuropathic localized
amyloidoses, with aggregate formation in tissues other than the brain,
and (iii) non-neuropathic systemic amyloidoses, where aggregates
occur in multiple tissues and organs [2]. In all of these abnormal
conditions, there is a consensus that soluble oligomers rather thanmature
ﬁbrils are cytotoxic and contribute to organ dysfunction, presumably byoxidative stress; ROS, reactive
dehydrogenase; GDH, glutamate
DTA, ethylenediaminetetraacetic
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rights reserved.interaction with and destabilization of cellular membranes [1–5]. This
is thought to occur either through formation of speciﬁc channels
(pores) and/or through a nonspeciﬁc detergent-like mechanism
[3,6,7]. However, deposits of ﬁbrillar materials in large amounts may
also affect the function of the organ mechanically [1,8]. In the case of
neurodegenerative diseases, internal organelles such as mitochondria
may be affected [9]. Indeed many recent ﬁndings have demonstrated
mitochondrial malfunction is the earliest and the most speciﬁc
character of a wide range of neurodegenerative conditions such as
Alzheimer's disease, Parkinson's disease, Huntington's disease and
amyotrophic lateral sclerosis (ALS) [10]. Clinically, mitochondrial
disorders are frequently referred to as nervous system disorders,
presumably due to second-to-second dependency on oxidative/energy
metabolism for brain function [11]. The main consequences of
mitochondrial dysfunction include loss of ATP production, impairment
of cellular calcium homeostasis and increased generation of reactive
oxygen species (ROS) [12]. Moreover, accumulation of mitochondrial
defects has been implicated as a mechanism of aging and age-related
diseases [12]. In these abnormal conditions, equilibrium between
generation and scavenging of ROS is disrupted, resulting in oxidative
stress (OS), generally viewed as a fundamental pathogenic mechanism
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meabilization by promoting Ca2+ uptake, which results in disruption
of proton gradient, the release of cytochrome c, and ultimately induction
of neuronal cell death [12,13]. However, the neural cell response to this
pervasive stress is not uniform in different regions of the brain [14–16].
This selective vulnerability may lead to neuronal cell death in deﬁned
populations of neurons andmay occur under awide range of deleterious
conditions other than OS, including calcium-induced mitochondrial
permeability transition and β amyloid-induced neurotoxicity [17,18].
Signiﬁcant differences in morphologies and biochemical characteristics
in different populations of neurons in different regions of the brain
have been found, resulting in high levels of heterogeneity [19]. In the
case of brain mitochondria, heterogeneity has been found to occur in
relation to structure, enzyme content, energy metabolism, motility and
compartmentation, suggesting differences in neuronal functional
capacities [20]. This would imply that dysfunction caused by interaction
of cytotoxic oligomers with membrane components may also occur to
different extents in different subpopulations of mitochondria. We have
recently reported on membrane permeabilization in rat brain
mitochondria upon interaction with HEWL oligomeric species, as
evidenced by release of mitochondrial enzymes and suggested possible
involvement ofmitochondrial heterogeneity [21]. In continuation of this
work, we have looked into this possibility by testing mitochondria
isolated from three different regions of the brain.
There are many reports suggesting a close relationship between
amyloid deposits and the different components of cell membrane
[1,4,5,22,23]. Biological membranes are very heterogeneous structures,
composed of a wide variety of lipids and proteins, which are
compartmentalized as dynamic self-organizedmembranemicrodomains
that selectively recruit speciﬁc proteins and lipids [24]. Of the cell
organelles, mitochondria are very complex, displaying various levels of
heterogeneity in morphology, function and biochemical properties,
between and within different cells [25–27]. In some localized
amyloidosis, including AD and Type 2 diabetes mellitus (T2DM),
mitochondrial membrane perturbation has been widely suggested as a
result of their associated protein oligomers [28,29]. Unlike neurological
disorders, amyloidosis involving extracellular aggregate formation
consists of a wide range of organs, such as the heart, kidneys, blood
vessels, central and peripheral nervous systems, liver, intestines, lungs,
eyes, skin, and bones, which display various levels of membrane
heterogeneity [1,2,4,30]. Accordingly, the second part of our study
involved the use of mitochondria isolated from two other tissues (liver
and heart). Together with the brain, these examples represent various
levels of heterogeneity in relation to composition and physico-chemical
properties, and different degrees of susceptibility to membrane perme-
abilization induced byHEWL oligomers. Formembrane permeabilization
to be initiated, HEWL oligomers must reach the mitochondrial surface. It
has been shown that protein recruitment to charged biomembranes is
facilitated by nonspeciﬁc and long-distance electrostatic interactions
[31], which may play an important role in localization of many proteins
containing polycationic domains [32]. Moreover, these interactions may
deﬁne orientation of attachment [33]. Accordingly, the positively-
charged segments of the oligomeric structures of lysozyme (pI of
11.35) [34], may be involved in guiding them to the mitochondrial
surface. This initial approach inﬂuenced by electrostatic forces may be
followed by insertion of the hydrophobic segments of the protoﬁbrillar
structures into the phospholipid bilayer.
2. Results and discussion
Protein deposition diseases are involved in various organs and
tissues [1,2]. Up to 24 different proteins have been recognized to
date to be amyloidogenic in humans and their roles in causing various
pathological conditions have been very actively investigated [30].
Membrane permeabilization has been widely suggested as a main
contributor to cytotoxicity [1–7]. However, heterogeneity in cellmembrane components has made it difﬁcult to understand the
molecular mechanisms through which protein deposits carry this
important function. Mitochondrial heterogeneity has been found to
occur at various levels including biochemical, morphological, functional,
dynamic, and pathological [25]. Heterogeneity in pathology means that
various subpopulations may vary in their sensitivity to deleterious
environmental factors such as OS or apoptosis [25].
In a recent communication we reported onmitochondrial membrane
permeabilization upon interaction with ﬁbrillation products obtained
from HEWL [21]. In the present study, we provide evidence suggesting
a regional vulnerability in brain mitochondria in relation to this
observation. A clear difference in the extent of membrane perme-
abilization in brain mitochondria as compared to those obtained from
the liver and heart is also reported. We conclude that the results
presented may provide important insights into the role of membrane
structure and heterogeneity in neurodegenerative conditions and the
reported non-uniform distribution of protein deposits in the various
organs causing other types of amyloidosis.
2.1. Structural–functional heterogeneity of mitochondria obtained from
various brain regions
Mitochondria isolated from different brain regions have been
shown to have distinct morphological and biochemical properties,
varying in terms of composition and sensitivity to various stress
conditions [17,20,35,36]. This may explain the role of impairments
in oxidative/energy metabolism in speciﬁc types of brain damage
and therefore speciﬁc neurological entities rather than overall brain
degeneration [11]. Selective vulnerability of a speciﬁc region of the
brain which may lead to progressive failure of a restricted population
of neuronal cells, is one of the most intriguing aspects of the
pathology of many neurodegenerative conditions, including AD, PD,
HD and ALS [37]. Although little is known about the underlying
mechanisms of this selective neuronal vulnerability, mitochondrial
heterogeneity appears to be one of the major factors [11,38,39]. High
baseline of OS, low ATP/energy reserves and mitochondrial dysfunction
are known as some of the major underlying factors contributing to
selectiveneuronalvulnerabilityunderneurodegenerativeconditions [19].
Accordingly, mitochondria are now believed to play a pivotal role in
governing the selective neuronal vulnerability in neurodegenerative
diseases [38].
In the present study, membrane permeabilization of mitochondria
from different areas of bovine brain was investigated following an
approach involving the release of mitochondrial enzymes, as described
recently [21]. The areas included cortex, hippocampus and substantia
nigra. Our results clearly demonstrate variations in the extent of
membrane permeability in the different regions (Fig. 1). The cortex
and hippocampus appeared to be more affected as compared to
substantia nigra (Fig. 1). These data are in accord with earlier reports
demonstrating selective vulnerability in brainmitochondria in response
to different destructive conditions [17,35,36]. Regional differences in
sensitivity to membrane permeabilization may be, at least partially, a
reﬂection of consistent variations in membrane composition and
enzyme content of mitochondria in different regions of the brain. This
may be one of the factors determining the extent of interaction with
and permeabilization of mitochondrial membranes upon exposure to
HEWL toxic oligomers. Interestingly, there is also selectivity in the
association of α-synuclein and superoxide dismutase 1 (SOD1) mutant
in PD and ALS with mitochondrial membrane, suggesting that some
speciﬁc features of composition–biophysical properties of this organelle
may determine the degree of their vulnerability [40,41]. Some other
reports in the literature also demonstrate that heterogeneity in
mitochondrial composition may account for selective vulnerability
under deleterious conditions [11,38]. For example, Ko et al. suggested
that selective loss ofα-ketoglutarate-dehydrogenase-enriched neurons
in AD brain could be contributed to such variations [39]. It is well
Fig. 1. Enzyme release upon interaction with HEWL oligomers from mitochondria
isolated from different regions of bovine brain. Mitochondrial suspensions (1 mg/ml
protein) prepared from hippocampus, cortex and substantia nigra were incubated
with 25 μM HEWL oligomers for 30 min followed by assaying for release of (a) MDH
and (b) CS, using the procedures described under the Materials and methods section.
Data corresponding to whole homogenate and controls (white bars) are also provided.
★, pb0.05; ★★, pb0.01; ★★★, pb0.001, signiﬁcantly different from control.
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and apoptotic cell death, presumably due to impairments of energy
metabolism [11]. An aspect of brain oxidative/energy metabolism isFig. 2.Mitochondrial enzyme release upon interaction with HEWL monomer, oligomer and ﬁ
bars), liver (white bars) and heart (light-gray bars) mitochondria. All measurements are expre
(0.5%) except for AK release, which are expressed relative to buffer. ★, pb0.05; ★★, pb0.01;
the brain mitochondria.non-uniform distribution of enzymes among different types of neurons.
This may lead to the hypothesis that heterogeneous distributions of
mitochondrial components, in the vulnerable and non-vulnerable
brain cells, could account for the differential susceptibilities in various
brain disorders [11]. These ﬁndings may provide some mechanistic
insights into selective degeneration of various regions in the brain,
conﬁrming cellular heterogeneity and the differential vulnerability of
the neuronal populations in various neurological conditions.2.2. Membrane permeabilization in mitochondria isolated from different
tissues
Cellular membranes, as primary targets, display large variations in
relation to their biochemical compositions and biophysical properties in
different tissues, which could result in heterogeneity in presentation
and clinical course related to these diseases [4,30]. Additionally,
membrane heterogeneity may play an important role in the genesis
and progression of different forms of amyloidosis and in their non-
uniform distribution. For instance, in some types of amyloidosis,
such as AL amyloidosis and senile systemic amyloidosis, selected
organs are targeted through interaction with matrix components and
cell membrane constituents [5,23]. These may result in the formation
of oligomeric species, and consequently tissue dysfunction.
Therefore, in continuation of the ﬁrst part of the present study
involving various brain areas, membrane permeabilization in liver
and heart mitochondria was also assessed. This was carried out by
looking at the release of mitochondrial enzymes as reported earlier
[21]. Exposure to HEWL ﬁbrillation products resulted in excessive
enzyme release (Fig. 2). It is clear from the data presented that
brain mitochondria possess a higher capacity to resist the effects as
compared to liver and heart mitochondria (Fig. 2). This is in accord
with the suggestions that brain mitochondria are more resistant to
calcium-induced membrane permeabilization promoted by interaction
with the amyloid β-peptide than liver mitochondria [42], and to
permeability transition induced by calcium when compared to liver
and heart mitochondria [43]. Heart mitochondria showed maximumbrils. Release of MDH (a), CS (b), GDH (c) and AK (d) is shown for rat brain (dark-gray
ssed as percentage of the maximum release observed upon treatment with Triton X-100
★★★, pb0.001, signiﬁcantly different from control. #, pb0.05, signiﬁcantly different from
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highest extent in liver mitochondria (Fig. 2). HEWL monomers were
nearly ineffective and release detected in the presence of ﬁbrils in
liver and heart mitochondria may be due to a mechanical disruption
process [1,8]. Mitochondria perform different functions in different
tissues [44]. For instance, the urea cycle takes place primarily in the
liver and oxidative phosphorylation and ATP generation is most active
in heartmitochondria [44]. Therefore, a simple explanation for differences
in sensitivity to protoﬁbril-inducedmembrane permeabilization between
liver and heart mitochondria might somehow be related to functional
differences in their mitochondrial populations (Table 1). Similarly,
differences in GDH content, an enzyme predominantly occurring in the
liver [45], could contribute to comparatively higher sensitivity of liver
mitochondria (Fig. 2c).
A growing body of evidence demonstrates that brain mitochondria
are more heterogeneous as compared to liver and heart mitochondria
[42,46,47], with regional differences in the brain as discussed in the
previous section. In addition to differences in heterogeneity, profound
differences would be expected to exist in their basic membrane
structure as an adaptation to their speciﬁc functions. Of such
differences, it is well known that phospholipid composition (both
type of phospholipid and nature of alkyl chains) may differ greatly.
Table 2 shows a summary of the main reported differences related to
rat brain, liver and heart mitochondria. The brain is an organ highly
enriched in cholesterol [48]. Furthermore, cholesterol is well known
for its modulating effects on membrane physical properties, such as
its ﬂuidity and lipid packing [49]. Alterations in cholesterol content
may induce changes in lipid–protein interactions and/or membrane
permeability properties [49]. In spite of controversial reports on the effect
of cholesterol on membrane properties, a large body of data is collected
on its inhibitory effect onmembrane insertion and permeability changes,
induced by a number of proteins, with pathological manifestations [49–
51]. By bringing about ﬂuidity changes (cholesterol makes membranes
more rigid) membrane incorporation of toxic proteins could be affected.
Particularly, cholesterol was found to prevent the perturbations of model
membrane polar regions induced by oligomeric species of lysozyme
[52]. Therefore, the very high content of cholesterol in brainmitochondria
may have important consequences in relation to its membrane function,
including protecting it against aggregate toxicity, by enhancing
membrane resistance against disassembly by the aggregates [53].
Accordingly, reduced levels of cholesterol have been reported in brains
of AD patients [54]. Of the membrane phospholipids, cardiolipin, a
structurally unique dimeric phospholipid almost exclusively found in
the mitochondrial inner membrane, encompasses a range of 10–20%
of total mitochondrial phospholipids, with exceptions being rat brain
mitochondria, which contain signiﬁcantly lower proportions of this
phospholipid [55]. A large body of evidence demonstrates a high
binding afﬁnity of amyloidogenic proteins involved in a number of
neurodegenerative disorders for acidic phospholipids, preferentially
for cardiolipin [56–58]. Interestingly, Trusova et al. reported electrostatic
attachment of lysozyme to the headgroup of anionic cardiolipin giving
rise to morphological changes on solid-supported lipid bilayers [59].
Additionally, higher levels of cardiolipin in liver and heart mitochondria
(compared to brain mitochondria, see Table 2) may result in increasing
sensitivity to membrane permeabilization caused by preﬁbrillarTable 1
Speciﬁc activities of mitochondrial enzymes.
MDH CS GDH
Brain 1.23±0.31 0.72±0.02 0.15±0.02
Liver 0.48±0.08 0.41±0.03 1.58±0.27
Heart 3.67±0.84 1.56±0.18 0.28±0.03
Activities are given as μmol/min/mg protein. Results are presented as mean±S.E.M. of
three observations.oligomers. Moreover, although our results suggest critical role of lipid
composition in membrane permeabilization, we have not taken into
account the effects of surface associated and/or integral membrane
proteins onHEWL protoﬁbril interactionwithmitochondrialmembrane.
Clearly, these factors may also have an effect on protoﬁbril–membrane
interactions whether as competitors of lipids for protein binding or as
modulators of membrane properties [60]. Therefore, quantitative
and qualitative differences in membrane lipids and proteins, in
mitochondria isolated from different tissues (see also Table 2), may
explain the observed differences in sensitivity related to the three organs
investigated. Heterogeneity in mitochondrial membrane curvature may
also play an important role [61]. Evidence suggests that bilayer defects
are mostly present in regions of vesicles with high curvatures [62].
Moreover, protein insertion into membrane has been shown to increase
in highly curved regions of membranes, such as the case reported for α-
synuclein [63]. Membrane asymmetry also contributes to heterogeneity.
It has been established that there are striking differences in the
phospholipid composition in the inner and outer leaﬂets as well as
non-uniform distributions in each of the leaﬂets of the bilayer structure.
Additionally, existence of segregated lipid domains may lead to local
heterogeneity. Such local clusters in a speciﬁc lipid type could provide
sensitive “hot-spots” which could contribute to disruption at speciﬁc
local sites and cause protein release as an initiation of apoptotic
events. Outer mitochondrial membrane has been shown to be very
heterogeneous with respect to protein component distribution in the
plane of membrane [64]. Mitochondria in all cell types go through
continuous cycles of fusion and ﬁssion [65], with the ﬁssion events
commonly generating uneven daughter mitochondria, differing in
membrane potential and the probability for subsequent fusion [66].
Furthermore, an unequal and incomplete mixing of mitochondrial
components has been shown to occur during fusion, further contributing
to mitochondrial heterogeneity [67]. Mitochondrial dynamics has
also been shown to play an important role in maintaining and
controlling heterogeneity, upon inhibition of which under abnormal
conditions (such as high stress), heterogeneity was found to increase
[68]. All these factors and events may contribute to heterogeneity in
mitochondrial permeabilization and the related mechanisms and
differences.
2.3. Effect of calcium on membrane permeabilization
In a recent study, we showed that brain mitochondrial membrane
permeability induced by HEWL oligomers was completely inhibited
by calcium, presumably by reducing the surface charge density and
inducing tighter packing of the phospholipids [21]. This effect of
calcium was also examined in the present study. As indicated in
Fig. 3, while enzyme release in brain mitochondria was strongly
inhibited by the presence of 5 mM calcium, liver and heartmitochondria
were affected to much lower extents. At concentrations greater than
5 mM, more release in liver and heart mitochondria was observed
(data not shown), presumably due to some non-speciﬁc effects. Since
surface charge density would be expected to play an important role in
the protection afforded by the presence of this counterion, surface
potential measurements were made. Results presented in Fig. 4, clearly
demonstrate more negative zeta potential at the surface of brain
mitochondria as compared to liver and heart mitochondria. In accord
with this observation, calcium was found to be more effective in
neutralizing surface potential of brain mitochondria than for the
other two cases (Fig. 5). Another distinctive feature of brain tissue is
its high content of gangliosides, a group of sialic acid containing
glycosphingolipids, mainly enriched in microsomal and mitochondrial
membranes [69]. This may explain some of the observations discussed
above. Additionally, sialic acid has been shown to contribute toward
calcium binding capacity in heart and red blood cell membranes
[70,71]. High contents of negatively charged phospholipids in brain
mitochondria, including phosphatidyl serine and phosphatidyl inositol
Table 2
Comparison of phospholipid composition and membrane ﬂuidity in rat brain, liver and heart mitochondria.




Brain 5.1±2.8 6.3±2.3 5.3±2.2 573±51 [55,84–87] 0.238±0.02 [84,85,87,93]
Liver 15.1±2.7 4.7±1.4 2.3±2.1 199±21 [55,87–91] 0.173±0.0 [87,93]
Heart 12.2±2.5 3.3±2.5 3.1±2.2 459±74 [55,87,91,92] 0.183±0.0 [87,93]
Data were collected from independent previous reports. TPL are expressed as μg/mg protein and anionic phospholipid contents are expressed as percentage of TPL. Membrane
ﬂuidity is indicated by ﬂuorescence polarization using DPH as probe. Ref. [1] and Ref. [2] are for membrane phospholipid composition and ﬂuidity, respectively. Data presented
are mean±S.E.M. of the 2–4 independent reports. TPL, total phospholipids; CL, cardiolipin; PI, phosphatidylinositol; PS, phosphatidylserine.
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observations demonstrate the crucial role of membrane charge density
in oligomer–membrane interaction and suggest that any alteration in
this property of the membrane may inﬂuence the binding afﬁnity
and/or insertion/disruption energy of HEWL protoﬁbrils.2.4. Effect of polyamines
Use of 100 mM spermine completely inhibited enzyme release in
brain mitochondria, while higher concentrations of the polyamine
were required for effective blockage in liver and heart mitochondria
(Fig. 6). This observation could be a consequence of higher surface
zeta potential in brain mitochondria, as discussed in the previous section.
Natural polyamines,which occur in themillimolar concentration range in
eukaryotic cells, exhibit remarkable stabilization effects on mitochondria
[72,73]. The polycationic characteristics of these molecules mediate their
binding to membrane anionic sites [73]. In the case of mitochondria, it
has been demonstrated that polyamines bind to inner mitochondrialFig. 3. Effect of calcium on release of MDH (a) and CS (b) upon interaction with HEWL
oligomers. Mitochondrial suspensions at 1 mg/ml protein concentration were
incubated on ice with various concentrations of calcium for 10 min, and release of
enzymes in rat brain (dark-gray bars), liver (white bars) and heart (light-gray bars)
mitochondria was determined. The procedures described under the Materials and
methods section were used to assay for release of enzymes. The value used for control
is enzyme release in the absence of additional calcium (taken as 100%). ★, pb0.05;
★★, pb0.01; ★★★, pb0.001, signiﬁcantly different from control.membrane at speciﬁc sites [74]. The interaction of polyamines with
mitochondria has several important physiological consequences,
including activation of calcium and phosphate transport and several
enzymes, inhibition of ATP hydrolysis (by F0F1ATPase), andmaintenance
of ATP concentration at high levels [74]. Moreover, substantial quantities
of spermine and spermidine are found in the mitochondrial matrix, and
the mitochondrial membrane possesses a speciﬁc transport system
for polyamines [74]. The main target of polyamines appears to be
mitochondrial permeability transition pore, a structure involved in
mitochondria-mediated cell death, where they exert a protective role
by both direct and indirect mechanisms [74,75].3. Concluding remarks
It has been clearly established that mitochondrial dysfunction is
the most common character of a wide range of protein-deposition
disorders. The main objective of the present study was to evaluate
involvement of mitochondrial heterogeneity in relation to membrane
permeabilization potential of HEWL protoﬁbrils, with a structure–
function approach. The mitochondrion as a vitally important organelle
consists of an ensemble of macromolecules, mainly proteins and
phospholipids, asymmetrically distributed at various levels.Mitochondria
in different tissues differ dramatically in morphology and physico-
chemical properties, tailored to their physiological function. Our results
clearly demonstrate differences in the behavior of these organelles
isolated from different regions of the brain and also in those prepared
from different tissues, all differing in structure and function. We argue
that the various levels of mitochondrial heterogeneity may be of major
physiological signiﬁcance in relation to amyloidosis. In addition to
providing useful insights into mechanisms of mitochondrial dysfunction,
we believe the type of approach taken in the present investigation may
provide useful information related to mechanism of disruption in other
biomembranes, all of which share some basic physico-chemical and
morphological characteristics. The brain consists of a large number of
anatomically-different regions, which regulate different functions, onlyFig. 4. Zeta potential measurements of mitochondrial suspensions prepared from rat
brain, liver and heart tissues. Results are presented as mean±S.E.M. of 5 observations.
Further details are described under the Materials and methods section.
Fig. 5. Effect of calcium on mitochondrial surface potential related to rat brain, liver and
heart tissues. Mitochondrial suspensions were diluted up to a ﬁnal concentration of
0.02 mg/ml in 20 mM Hepes (pH 7.5) and surface charge potential of preparations
from rat brain (dark-gray bars), liver (white bars) and heart (light-gray bars) tissues
was measured in the presence of a various concentrations of calcium (0–5 mM).
Further details are described in the Materials and methods section and legend of
Fig. 3. ★, pb0.05; ★★, pb0.01; ★★★, pb0.001, signiﬁcantly different from control.
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possible that greater differences in sensitivity of response ofmitochondria
to permeabilization by toxic oligomers exist in different areas of the brain,
with major physiological and pathological signiﬁcance.
4. Materials and methods
4.1. Materials
HEWL (EC 3.2.1.17), acetyl coenzyme A, 5,5-dithiobis-2-nitrobenzoic
acid (DTNB) and β-nicotinamide adenine dinucleotide, reduced formFig. 6. Effect of spermine on release of MDH (a) and CS (b) upon interaction with HEWL
oligomers. Mitochondrial suspensions at 1 mg/ml protein concentration were
incubated on ice with various concentrations of spermine for 10 min, and release of
enzymes in rat brain (dark-gray bars), liver (white bars) and heart (light-gray bars)
mitochondria was determined. The procedures described under the Materials and
methods section were used to assay for release of enzymes. The value used for control
is enzyme release at zero concentration of spermine (taken as 100%). ★, pb0.05;
★★, pb0.01; ★★★, pb0.001, signiﬁcantly different from control.(β-NADH), were purchased from Sigma (St. Louis, MO, USA). D-
Luciferin was obtained from Synchem Corp. All other chemicals were
obtained from Merck (Darmstadt, Germany) and were reagent grade.
4.2. Preparation of HEWL oligomers and ﬁbrillar aggregates
Preparation of oligomers and ﬁbrillar aggregates was performed
as previously reported [21]. The structures were characterized
using a range of techniques, including ﬂuorescence, size-exclusion
chromatography, dynamic light scattering, transmission electron
microscopy, dot blot analysis and circular dichroism [21]. To increase
the yield of oligomeric species, aliquots from protein samples incubated
forﬁve dayswere taken and centrifuged at 21,000 g for 30 min to remove
any insoluble aggregates. The resulting supernatant was then concen-
trated 4–5 times by employing a Vivaspin (Sartorius) concentrator with
a 100 kDa molecular weight cutoff. Size-exclusion chromatography and
1-anilino-naphthalene 8-sulfonate (ANS) ﬂuorescence runs indicated
enrichment of oligomers containing exposed hydrophobic residues [21].
4.3. Preparation of mitochondria
Mitochondria from male rat brains were prepared by differential
centrifugation as described earlier [21]. Rat liver mitochondria were
isolated in a medium containing [10 mM Tris–HCl (pH 7.4), 1 mM
ethylenediaminetetraacetic acid (EDTA), 0.1% (w/v) bovine serum
albumin (BSA), 0.32 M sucrose and 0.25 mM phenylmethylsulfonyl
ﬂuoride (PMSF)], by differential centrifugation of liver homogenates,
using a slightly modiﬁed protocol of Bustamante et al. [76]. Brieﬂy,
livers from male rat were excised, washed and homogenized in 2
volumes of pre-cooled isolation buffer. The homogenate was then
centrifuged at 1000 g for 15 min. The resulting supernatant containing
mitochondrial fraction was centrifuged at 10,000 g for 15 min, and the
pellet was resuspended in the same buffer and was centrifuged again,
as above. As for heart mitochondria, the procedure described by
Di Paola et al. [77] was employed with some modiﬁcations. Brieﬂy,
hearts from male rats were quickly excised, carefully devoided of fat
and connective tissue, and then homogenized in 10 volumes of pre-
cooled isolation buffer. The homogenate was centrifuged at 1200 g for
10 min, the pellet was discarded and the resulting supernatant was
centrifuged at 9500 g for 10 min. The new pellet was resuspended in
the same isolation buffer and was centrifuged at 14,000 g for two
additional times. In all mitochondrial preparation runs, ﬁnal pellets
were resuspended in the isolation medium at a protein concentration
of 15–20 mg/ml, as determined by the method of Lowry et al. [78]. All
centrifugation steps were carried out at 4 °C. Mitochondrial membrane
integrity was conﬁrmed by determination of speciﬁc activities of
marker enzymes: MDH, GDH, rotenone-insensitive NADH-cytochrome
c reductase, cytochrome c oxidase, CS and AK, in addition to checking
for retention of cytochrome c, as described previously [79,21].
4.4. Preparation of mitochondria from different sections of bovine brain
Brain regions of interest including cortex, hippocampus and
substantia nigra were carefully dissected following anatomical
guidelines, and homogenized in 2 volumes of ice-cold isolation
buffer [10 mM Tris–HCl (pH 7.4), 1 mM EDTA, 0.1% (w/v) BSA and
0.32 M sucrose]. No attention was paid toward obtaining the
samples from any speciﬁc areas of the brain regions. The isolation
procedure was as described for rat brain whole homogenate.
4.5. Treatment of mitochondria with HEWL monomer and its ﬁbrillation
products
Mitochondrial preparations were treated with HEWL monomer
and its ﬁbrillation products as described earlier [21]. Brieﬂy, aliquots
of solutions containing HEWL monomer, oligomers and ﬁbrils (and
2155A.A. Meratan, M. Nemat-Gorgani / Biochimica et Biophysica Acta 1818 (2012) 2149–2157glycine buffer used as control) were added to 200 μl of mitochondrial
homogenate (ﬁnal concentration of 1 mg/ml), followed by incubation
for 30 min at 30 °C. Triton X-100 (at a ﬁnal concentration of 0.5%) was
used as positive control for maximum release. At the end of the
incubation period, mitochondrial suspensions were centrifuged at
21,000 g for 15 min, and resulting supernatants were tested for release
of mitochondrial enzymes. Data are expressed as a fraction of the
maximum effect (Triton X-100): (measured signal−blank signal)/
(maximum signal−blank signal). Since Triton X-100 interferes with
the luciferase luminescence assay, AK activities are expressed relative
to control.
4.6. Determination of mitochondrial enzyme release
Release of enzymes was determined by following activity measure-
ments as detailed below.
4.6.1. AK activity determination
A bioluminometric assay was used for AK activity determination as
described by Wu et al. with some modiﬁcations [80]. The experiment
was carried out exactly as reported recently [21] and luminescent signal
was recorded as relative light unit using a Synergy Hybrid Multi-Mode
microplate reader (BioTek Instruments, Winooski, VT 05404-0998,
USA).
4.6.2. MDH activity determination
MDH activity was measured spectrophotometrically as described
by Sottocasa et al. [81]. The basic assay mix [56 mM Tris–HCl and
5.6 mM oxaloacetate (pH 7.5)] contained 0.1 mM NADH, in a ﬁnal
volume of 0.5 ml. Enzymatic activity was determined by starting the
reaction with 10 μl of mitochondrial suspension and the rate of
decrease in absorbance due to NADH oxidation was measured at
340 nm, using an extinction coefﬁcient of 6.22 mM−1 cm−1.
4.6.3. GDH activity determination
GDH activity was measured spectrophotometrically essentially as
described by Dodd and Radda [82]. The basic assay mix [100 mM
K2HPO4, 5.55 mM α-ketoglutarate, 55.5 mM NH4Cl and 0.2 mM
EDTA (pH 7.8)] contained 20 μM NADH, in a ﬁnal volume of 0.5 ml.
Activity determination was made by starting the reaction with 20 μl
of mitochondrial suspension and the decrease in absorbance was
measured as described above, for MDH.
4.6.4. CS activity determination
CS activity was measured spectrophotometrically as described by
Muller-Kraft and Babel [83]. The assay medium consisted of 100 mM
Tris–HCl, 1 mMDTNB, 50 mMoxaloacetate and 5 mM acetyl coenzyme
A (pH 8). The reaction was started with 10 μl of mitochondrial
suspension and the increase in absorbance was measured at 412 nm,
using an extinction coefﬁcient of 13.6 mM−1 cm−1.
4.7. Zeta potential measurements
A zeta potential and particle size analyzer (Brookhaven Instrument,
Holtsville, NY 11742-1896, USA) was used for this purpose. Aliquots of
mitochondrial suspensions were added to a ﬁltrated 20 mM Hepes
buffer (pH 7.5) in a ﬁnal concentration of 0.02 mg/ml and surface
charge potential of mitochondrial membranes was measured in the
absence and presence of various concentrations of calcium (0–5 mM).
Each experiment was performed at least ﬁve times.
4.8. Statistical analysis
All experiments were performed at least three times with triplicate
assays. The results are presented as mean±standard deviation, and a
Student's paired t-test was utilized to calculate the statistical signiﬁcance.Acknowledgement
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